+Follow
琪琪小不点
No personal profile
49
Follow
23
Followers
0
Topic
0
Badge
Posts
Hot
琪琪小不点
2021-03-15
$Zomedica Pharmaceuticals Corp.(ZOM)$
???
琪琪小不点
2021-03-08
$Zomedica Pharmaceuticals Corp.(ZOM)$
???
琪琪小不点
2021-03-03
???
U.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%
琪琪小不点
2021-02-05
???
Sorry, the original content has been removed
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3566178813813075","uuid":"3566178813813075","gmtCreate":1603089103749,"gmtModify":1611910048661,"name":"琪琪小不点","pinyin":"qqxbdqiqixiaobudian","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":23,"headSize":49,"tweetSize":177,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":38,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.88%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.59%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":322204758,"gmtCreate":1615807374874,"gmtModify":1704786792891,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566178813813075","idStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322204758","isVote":1,"tweetType":1,"viewCount":1936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329805366,"gmtCreate":1615218140155,"gmtModify":1704779778414,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566178813813075","idStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/329805366","isVote":1,"tweetType":1,"viewCount":2273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365429140,"gmtCreate":1614772694980,"gmtModify":1704775019718,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566178813813075","idStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/365429140","repostId":"2116549921","repostType":2,"repost":{"id":"2116549921","kind":"news","pubTimestamp":1614771676,"share":"https://ttm.financial/m/news/2116549921?lang=en_US&edition=fundamental","pubTime":"2021-03-03 19:41","market":"us","language":"zh","title":"U.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2116549921","media":"智通财经网","summary":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","content":"<p><html><body><article>Zhitong Finance APP learned that before the U.S. stock market opened on March 3 (Wednesday), the stock price of Ocugen (OCGN.US) soared. As of 19:40 Beijing time, the stock rose 42.68% to US $13.64. Previously, the company announced that the mid-term effectiveness of the Novel Coronavirus vaccine jointly developed with Indian biotechnology company Bharat Biotech was 81%.</p><p></article></body></html></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经网</strong><span class=\"h-time small\">2021-03-03 19:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body><article>Zhitong Finance APP learned that before the U.S. stock market opened on March 3 (Wednesday), the stock price of Ocugen (OCGN.US) soared. As of 19:40 Beijing time, the stock rose 42.68% to US $13.64. Previously, the company announced that the mid-term effectiveness of the Novel Coronavirus vaccine jointly developed with Indian biotechnology company Bharat Biotech was 81%.</p><p></article></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b\">智通财经网</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d","relate_stocks":{"OCGN":"Ocugen"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2116549921","content_text":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":1874,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":380883531,"gmtCreate":1612532597623,"gmtModify":1704872472829,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566178813813075","idStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/380883531","repostId":"1170935467","repostType":4,"isVote":1,"tweetType":1,"viewCount":1732,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":329805366,"gmtCreate":1615218140155,"gmtModify":1704779778414,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566178813813075","idStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/329805366","isVote":1,"tweetType":1,"viewCount":2273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":380883531,"gmtCreate":1612532597623,"gmtModify":1704872472829,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566178813813075","idStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/380883531","repostId":"1170935467","repostType":4,"repost":{"id":"1170935467","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1612532073,"share":"https://ttm.financial/m/news/1170935467?lang=en_US&edition=fundamental","pubTime":"2021-02-05 21:34","market":"us","language":"zh","title":"U.S. non-farm payrolls increased by 49,000 in January, and the unemployment rate hit a new low in nearly a year","url":"https://stock-news.laohu8.com/highlight/detail?id=1170935467","media":"老虎资讯综合","summary":"美国1月季调后新增非农就业人口（万人）：4.9 ，预期：5，前值：-14。美国1月失业率：6.3% ，为去年3月以来新低。预期：6.7%，前值：6.7%。美国12月贸易帐（亿美元）：-666 ，预期：","content":"<p>The seasonally adjusted new non-farm employment population in the United States in January (10,000 people):<b>4.9</b>, expected: 5, previous value:-14.</p><p>U.S. January unemployment rate:<b>6.3%</b>, the lowest since March last year. Expected: 6.7%, previous value: 6.7%.</p><p>U.S. trade balance in December ($100 million):<b>-666</b>, expected:-657, previous value:-681.</p><p>U.S. Department of Labor: Significant gains in jobs in professional and business services and public and private education were offset by losses in jobs in leisure and hospitality, retail trade, health care, transportation and warehousing in January.</p><p>Analyst Chris Anstey: The market's forecast for today's non-agricultural data is very wide, from a decrease of 250,000 jobs to an increase of 400,000 jobs, which shows how difficult it is to assess the economic situation under the influence of so many factors. The final announcement showed that the number of new jobs was 49,000, which was lower than most expectations.</p><p>Analyst JOSEPH: Despite the disappointing non-farm payrolls data, so far, the market has largely maintained the position it held before the data was released. But as the U.S. economy grows and employment stagnates or loses in the EU, Japan and Canada, the dollar will benefit from the non-farm payrolls report.</p><p>CNBC commented on U.S. non-agricultural data for January: The employment situation remains challenging, with millions of people still unemployed after companies laid off employees in March and April 2020 to fight the epidemic. More than half of the unemployed have returned to work, but employment in most sectors remains below pre-pandemic levels, with employment in the hospitality sector being particularly damaged. While the next few months may remain challenging, COVID-19 vaccine offers hope that the U.S. economy is going full speed in the second half of the year. U.S. GDP fell 3.5% in 2020, and the outlook for the first quarter, especially 2021, remains uncertain. While most economic data exceeded expectations, there remained concerns that the persistence of the pandemic could hinder the proper functioning of economic activity at the beginning of the year.</p><p>After the data was released, U.S. Treasury Bond interest rates fell, and the futures of the three major U.S. stock indexes fluctuated little, all maintaining an upward trend.</p><p><img src=\"https://static.tigerbbs.com/2cb591ab9d223f2344e12216bf2c8d1c\" tg-width=\"685\" tg-height=\"250\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. non-farm payrolls increased by 49,000 in January, and the unemployment rate hit a new low in nearly a year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. non-farm payrolls increased by 49,000 in January, and the unemployment rate hit a new low in nearly a year\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2021-02-05 21:34</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>The seasonally adjusted new non-farm employment population in the United States in January (10,000 people):<b>4.9</b>, expected: 5, previous value:-14.</p><p>U.S. January unemployment rate:<b>6.3%</b>, the lowest since March last year. Expected: 6.7%, previous value: 6.7%.</p><p>U.S. trade balance in December ($100 million):<b>-666</b>, expected:-657, previous value:-681.</p><p>U.S. Department of Labor: Significant gains in jobs in professional and business services and public and private education were offset by losses in jobs in leisure and hospitality, retail trade, health care, transportation and warehousing in January.</p><p>Analyst Chris Anstey: The market's forecast for today's non-agricultural data is very wide, from a decrease of 250,000 jobs to an increase of 400,000 jobs, which shows how difficult it is to assess the economic situation under the influence of so many factors. The final announcement showed that the number of new jobs was 49,000, which was lower than most expectations.</p><p>Analyst JOSEPH: Despite the disappointing non-farm payrolls data, so far, the market has largely maintained the position it held before the data was released. But as the U.S. economy grows and employment stagnates or loses in the EU, Japan and Canada, the dollar will benefit from the non-farm payrolls report.</p><p>CNBC commented on U.S. non-agricultural data for January: The employment situation remains challenging, with millions of people still unemployed after companies laid off employees in March and April 2020 to fight the epidemic. More than half of the unemployed have returned to work, but employment in most sectors remains below pre-pandemic levels, with employment in the hospitality sector being particularly damaged. While the next few months may remain challenging, COVID-19 vaccine offers hope that the U.S. economy is going full speed in the second half of the year. U.S. GDP fell 3.5% in 2020, and the outlook for the first quarter, especially 2021, remains uncertain. While most economic data exceeded expectations, there remained concerns that the persistence of the pandemic could hinder the proper functioning of economic activity at the beginning of the year.</p><p>After the data was released, U.S. Treasury Bond interest rates fell, and the futures of the three major U.S. stock indexes fluctuated little, all maintaining an upward trend.</p><p><img src=\"https://static.tigerbbs.com/2cb591ab9d223f2344e12216bf2c8d1c\" tg-width=\"685\" tg-height=\"250\" referrerpolicy=\"no-referrer\"></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f866f5d880ac7442ed06621cdcccdbfd","relate_stocks":{".DJI":"道琼斯"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170935467","content_text":"美国1月季调后新增非农就业人口（万人）：4.9 ，预期：5，前值：-14。美国1月失业率：6.3% ，为去年3月以来新低。预期：6.7%，前值：6.7%。美国12月贸易帐（亿美元）：-666 ，预期：-657，前值：-681。美国劳工部：1月，专业和商业服务以及公共和私人教育领域就业岗位的显著增加被休闲和招待、零售贸易、保健、运输和仓储领域的就业岗位减少所抵消。分析师Chris Anstey：市场对今天非农数据预测的范围非常大，从减少25万个工作岗位到增加40万个工作岗位，这显示出，在存在如此多因素的影响下，评估经济状况有多么困难。最终公布值显示新增就业人数4.9万，这低于多数的预期值。分析师JOSEPH：尽管非农数据令人失望，但迄今为止，市场基本上保持了数据公布之前的头寸。但随着美国经济增长，欧盟、日本和加拿大就业停滞或就业岗位减少，美元将受益于非农报告。CNBC评美国1月非农数据：就业形势仍然具有挑战性，公司在2020年3月和4月为抗击疫情而进行裁员后，仍有数百万人失业。失业人群的一半以上已经回归工作岗位，但大多数部门的就业人数仍低于疫情前的水平，酒店行业的就业情况受损尤为严重。尽管接下来的几个月可能仍然充满挑战，但新冠疫苗为美国经济在下半年全速运转提供了希望。美国GDP在2020年下降了3.5%，第一季度特别是2021年的前景仍然不确定。尽管大多数经济数据都超出了预期，但人们仍然担心，疫情的持续存在可能会妨碍年初经济活动的正常运行。数据公布后，美国国债利率下跌，美股三大指数期货波动不大，均维持上涨走势。","news_type":1,"symbols_score_info":{".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":1732,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322204758,"gmtCreate":1615807374874,"gmtModify":1704786792891,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566178813813075","idStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322204758","isVote":1,"tweetType":1,"viewCount":1936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365429140,"gmtCreate":1614772694980,"gmtModify":1704775019718,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3566178813813075","idStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/365429140","repostId":"2116549921","repostType":2,"repost":{"id":"2116549921","kind":"news","pubTimestamp":1614771676,"share":"https://ttm.financial/m/news/2116549921?lang=en_US&edition=fundamental","pubTime":"2021-03-03 19:41","market":"us","language":"zh","title":"U.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2116549921","media":"智通财经网","summary":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","content":"<p><html><body><article>Zhitong Finance APP learned that before the U.S. stock market opened on March 3 (Wednesday), the stock price of Ocugen (OCGN.US) soared. As of 19:40 Beijing time, the stock rose 42.68% to US $13.64. Previously, the company announced that the mid-term effectiveness of the Novel Coronavirus vaccine jointly developed with Indian biotechnology company Bharat Biotech was 81%.</p><p></article></body></html></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stock changes | Ocugen (OCGN.US) rose more than 40% before the market, and the medium-term effectiveness of the COVID-19 vaccine jointly developed with Bharat Biotech was 81%\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经网</strong><span class=\"h-time small\">2021-03-03 19:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body><article>Zhitong Finance APP learned that before the U.S. stock market opened on March 3 (Wednesday), the stock price of Ocugen (OCGN.US) soared. As of 19:40 Beijing time, the stock rose 42.68% to US $13.64. Previously, the company announced that the mid-term effectiveness of the Novel Coronavirus vaccine jointly developed with Indian biotechnology company Bharat Biotech was 81%.</p><p></article></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b\">智通财经网</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d","relate_stocks":{"OCGN":"Ocugen"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2116549921","content_text":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":1874,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
